All Posts: News Release
-
Patient Groups Untested in Cancer Immunotherapy Trials Found to Also Benefit
A study by Georgetown Lombardi Comprehensive Cancer Center physicians indicates that cancer patients with HIV or viral hepatitis, along with African Americans, who have been underrepresented in or excluded from most clinical trials, benefit from immunotherapy for cancer treatment at the same rate as other patients.
Category: News Release
-
Significant ‘Knowledge Gap’ Exists in Use of Genetic Testing to Decide Cancer Treatment
A survey aimed at assessing how well community oncologists understand “molecular profiling” results from tumor specimens found that 69 percent of participants either said they don’t know the answers, or they responded incorrectly.
Category: News Release
-
Georgetown University’s Cancer Center Receives Coveted ‘Comprehensive Cancer Center’ Status from the National Cancer Institute
WASHINGTON (May 7, 2019) — The National Cancer Institute (NCI) has renewed Georgetown Lombardi Comprehensive Cancer Center’s designation as a “comprehensive cancer center,” a distinction first awarded to Georgetown Lombardi in 1974. Of the 1,500 cancer programs in the U.S., only 50 are NCI-designated comprehensive cancer centers and Georgetown Lombardi is the only such center in the Washington, D.C., area. The […]
Category: News Release
-
Washington Women Raise $735K for Breast Cancer Research at Georgetown Lombardi
WASHINGTON (April 25, 2019) — Women & Wine, one of Washington’s largest annual philanthropic events by and for women, raised over $735K at its April 24 annual event, with proceeds designated for research and treatment at the Nina Hyde Center for Breast Cancer Research at Georgetown Lombardi Comprehensive Cancer Center. Women & Wine is one of the premier events for […]
Category: News Release
-
Genetic Testing in Women Diagnosed with Breast Cancer Decreases Cost of Care Nationwide
A new study by Georgetown Lombardi Comprehensive Cancer Center and National Cancer Institute researchers suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million and offer women valuable information about treatment options.
Category: News Release
-
Rare but Important Gene Target Found in Many Tumor Types, Suggesting New Therapy Possible
A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer types.
Category: News Release
-
Georgetown Lombardi Director Louis Weiner Receives AACR 2019 Distinguished Public Service Award
The American Association for Cancer Research honored Georgetown Lombardi Comprehensive Cancer Center director Louis M. Weiner, MD, with a 2019 AACR Distinguished Public Service Award.
Category: News Release
-
Large Study Reveals Long-Term Outcomes for Prostate Cancer Patients Treated with High Dose, Short Term Radiation
A new study conducted at cancer centers around the country, including at Georgetown Lombardi Comprehensive Cancer Center, supports the routine use of a radiation treatment for prostate cancer that delivers a high dose of therapy in a very short time frame.
Category: News Release
-
Study Finds HIV+ Cancer Patients Benefit From Immunotherapy
The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Georgetown Genetic Counselor Offers Insight on Direct-to-Consumer DNA Testing Kits
Direct-to-consumer DNA testing kits have become popular holiday gifts. However, genetic counselor Beth N. Peshkin, MS, LCGC, of Georgetown University School of Medicine and Georgetown Lombardi Comprehensive Cancer Center encourages consumers to understand the pros and cons before gifting or using one of these kits.
Category: News Release